|
DDX46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33330000040566E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01869999996818E-07 |
| Normal-vs-Stage2 |
6.759900E-04 |
| Normal-vs-Stage3 |
5.978600E-04 |
| Normal-vs-Stage4 |
5.651500E-02 |
| Stage1-vs-Stage2 |
8.159600E-01 |
| Stage1-vs-Stage3 |
8.775800E-01 |
| Stage1-vs-Stage4 |
9.562200E-01 |
| Stage2-vs-Stage3 |
9.272200E-01 |
| Stage2-vs-Stage4 |
9.120200E-01 |
| Stage3-vs-Stage4 |
9.671000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.70849999983724E-07 |
| Normal-vs-AfricanAmerican |
1.81634999999458E-05 |
| Normal-vs-Asian |
1.958640E-04 |
| Caucasian-vs-AfricanAmerican |
8.489800E-01 |
| Caucasian-vs-Asian |
4.425400E-01 |
| AfricanAmerican-vs-Asian |
4.342800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65430000201405E-09 |
| Normal-vs-Female |
5.968000E-02 |
| Male-vs-Female |
1.840180E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.356060E-04 |
| Normal-vs-Extreme_Weight |
6.75120004345331E-09 |
| Normal-vs-Obese |
1.016560E-04 |
| Normal-vs-Extreme_Obese |
2.247800E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.323800E-01 |
| Normal_Weight-vs-Obese |
4.757800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.077000E-01 |
| Extreme_Weight-vs-Obese |
7.493900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.602800E-01 |
| Obese-vs-Extreme_Obese |
3.737200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.242800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.190300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.91680004990991E-09 |
| Normal-vs-Age(81-100Yrs) |
2.43350000039833E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.856200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.391400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.756300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.956420E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.024900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.61920000133031E-08 |
| Normal-VS-Type2 PRCC |
4.56879999999327E-06 |
| Normal-VS-KIRP CIMP |
9.319700E-02 |
| Normal-VS-Unclassified PRCC |
1.183640E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.387000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.401000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.582300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.249400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.189600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.208600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78250000315572E-08 |
| Normal-vs-N1 |
8.916100E-02 |
| Normal-vs-N2 |
2.515400E-01 |
| N0-vs-N1 |
3.167500E-02 |
| N0-vs-N2 |
7.238600E-01 |
| N1-vs-N2 |
5.662200E-01 |
|
|
